Product Information
RASUVO 15 MG/0.3 ML AUTOINJ is a brand product labeled by Medexus Pharma Inc., priced at $478.2833 per ML under NDC 59137052004. Its NADAC has been published 392 times since Feb 21, 2018.
FDA first approved this application on Jul 10, 2014.
The High Outlier badge above means this manufacturer's average price in the methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/.3mL
Manufacturer
Medexus Pharma Inc.NDC
59137052004
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA205776FDA Approved
7/10/2014
On Market Since
7/10/2014
Pharmacological Classes
Price Statistics
The NADAC for RASUVO 15 MG/0.3 ML AUTOINJ has been published 392 times since Feb 21, 2018, and over the history we have for it it has risen 26.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $478.2833 per ML |
|---|---|
| All-time high | $482.2921 (Aug 12, 2026) |
| All-time low | $378.5083 (Feb 21, 2018) |
| 52-week high | $482.2921 |
| 52-week low | $469.6032 |
| Median price | $423.9726 |
| Average price | $427.0506 |
| Largest weekly change | +5.8% (Feb 19, 2020) |
| Weeks tracked | 392 |
| Tracking since | Feb 21, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RASUVO 15 MG/0.3 ML AUTOINJ?
The current National Average Drug Acquisition Cost (NADAC) for RASUVO 15 MG/0.3 ML AUTOINJ, manufactured by Medexus Pharma Inc., is $478.2833 per ML (NDC 59137052004), effective Aug 19, 2026.
How has the price of RASUVO 15 MG/0.3 ML AUTOINJ changed over time?
Over the history we have for it, the NADAC for RASUVO 15 MG/0.3 ML AUTOINJ has risen 26.4%. It has been tracked across 392 weekly CMS publications since Feb 21, 2018.
What are the highest and lowest recorded NADAC prices for RASUVO 15 MG/0.3 ML AUTOINJ?
Since Feb 21, 2018, the NADAC for RASUVO 15 MG/0.3 ML AUTOINJ has ranged from a low of $378.5083 (Feb 21, 2018) to a high of $482.2921 (Aug 12, 2026), with a median of $423.9726 per ML.
Are there cheaper alternatives to RASUVO 15 MG/0.3 ML AUTOINJ?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RASUVO 15 MG/0.3 ML AUTOINJ in a comparable dosage form, but none are currently priced below it.
Who manufactures RASUVO 15 MG/0.3 ML AUTOINJ?
RASUVO 15 MG/0.3 ML AUTOINJ (NDC 59137052004) is labeled by Medexus Pharma Inc., and CMS classifies it as a brand product.